SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: billy d who wrote (385)8/22/1997 12:12:00 PM
From: James Silverman   of 10280
 
Billy and friends,
I spoke this morning with a friend who is a patent attourney for his opinion on the PBIO section of the SEPR 10Q. His opinion was as follows: the July opinion cited here as a negative is not one at all, in fact the way the law works if the patent is corrected it can only be corrected in a manner that is favorable to BSEP/SEPR. This is because the April ruling already essentially stated that PBIO acted with deceptive intent. So to change the inventorship can work in 2 ways. First, PBIO inventors would be removed and the BSEP inventors would be inserted. None of the original patent holders can be reinstated in a change. Two, the PBIO patents would stand but be nonenforcable, given prior deceptive intent ruling. So the patents can only be corrected if PBIO is removed from them.
In his opinion, based on the April ruling, PBIO is on the run, so to speak and the July note was not a negative by any means.
Of course, do your own homework, I can't vouch for the accuracy of any of the above.

As to HMSR and BSEP, I see no reason to unload these stocks at these paltry levels.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext